MDS Podcast

Shifts in the Society and the landscape of the field are set to guide growth in medical education. Dr. Veronica Santini shares insights about this new direction with Dr. Sara Schaefer and our listeners.

Following a year of impactful neuroimaging papers, Prof. Oury Monchi discusses with Dr. Michele Matarazzo the most promising advances involving machine learning, tracers, and precision in determining imaging processes.

The lines between functional and organic are blurring, as a promising opportunity to develop outcome measurements arises. Dr. Alberto Espay discusses with Dr. Sara Schaefer these and other advancements in functional movement disorders.

As tic cases rise, Dr. Christos Ganos overviews with Dr. Hugo Morales two major treatment advancements, a growing emphasis on neurostimulation research and multidisciplinary care, and progress in the field's largest area of opportunity.

Promising results on potential treatments, biomarkers, genetic predictors and more in dystonia were presented at the MDS Congress. Dr. Florence Chang highlights the key takeaways with Dr. Hugo Morales.

Wearable sensors, electronic rating scales, eDiaries — Dr. Álvaro Sánchez-Ferro discusses with Dr. Michele Matarazzo how these and a broad range of other emerging digital technologies can help take movement disorder evaluation outside the clinic and into patients' everyday environment.

"A Multi-Step Model of Parkinson's Disease Pathogenesis" was awarded "Best Research Article of the Movement Disorders journal for 2022." Dr. Michele Matarazzo interviews the first author, Dr. Campbell Le Heron. Read the article

A re-release of the episode featuring the recently-awarded "Best Review article of 2022 from the Movement Disorders journal" article, titled "The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy." Read the article.

Dr. Eduardo de Pablo-Fernández speaks with Dr. Dilan Athauda about his recent paper, "The impact of type 2 diabetes in Parkinson's disease" recently published in Movement Disorders. They discuss the clinical impact of type 2 diabetes in the phenotype and disease progression and the therapeutic implications of this association. Read the article.

Dr. Sara Schaefer speaks with Drs. Gregoire Courtine and Jocelyne Bloch about the use of an implanted spinal cord stimulator for the treatment of orthostatic hypotension in multiple-system atrophy. Read the article.